Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business
Source: SeekingAlpha
2026-03-12 17:42:55 ET
More on Champions Oncology
- Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
- Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
- Champions Oncology signals expanding radiolabeling and data platform as margin improves to 52%
- Financial information for Champions Oncology
Read the full article on Seeking Alpha
For further details see:
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business
Champions Oncology Inc.
NASDAQ: CSBR
CSBR Trading
-4.24% G/L:
$5.65 Last:
5,122 Volume:
$5.51 Open:
CSBR Latest News
March 05, 2026 04:00:00 pm
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
December 15, 2025 04:00:00 pm
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
December 08, 2025 04:00:00 pm
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
CSBR Stock Data
$91,233,162
4,971,305
0.69%
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Hackensack
